Posts in category Exclusive


Joel Greenblatt’s Magic Formula Says No to Two Pharma Giants: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD)

Why this Wall Street hedge fund legend sold VRX and GILD?

Read more

Ex-Harvard Endowment Bosses Make Surprise Bet on Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Say Goodbye to Valeant Pharmaceuticals Intl Inc (VRX)

This billion-dollar hedge fund initiates new position in struggling pharma TEVA as exits VRX.

Read more

Raising 2018 Bitcoin Price Target to $28,000

I am not trying to be a hero and compete with people on the Internet …

Read more

Investing Legend Joel Greenblatt Takes the Plunge on Micron Technology, Inc. (MU), Pulls Back on Apple Inc. (AAPL)

How does Greenblatt’s magic formula apply to MU and AAPL right now?

Read more

The World’s Top Fund Manager Jim Simons Bought a Big Chunk of Valeant Pharmaceuticals Intl Inc (VRX), Reduced Exposure to Opko Health Inc. (OPK)

Is Billionaire fund guru Jim Simons switching OPK for VRX?

Read more

Fund Guru Dmitry Balyasny Throws in the Towel on Advanced Micro Devices, Inc. (AMD) and Micron Technology, Inc. (MU)

Is the semiconductor party over? Hedge fund whizz Balyasny exits AMD while slashing MU stock.

Read more

Billionaire Ken Griffin Makes Waves in the Semiconductor World: Advanced Micro Devices, Inc. (AMD), NVIDIA Corporation (NVDA)

This fund guru is bullish on chip giants AMD and Nvidia.

Read more

Illinois’ Richest Man Ken Griffin Sees Potential Opportunities in Healthcare: Valeant Pharmaceuticals Intl Inc (VRX), Teva Pharmaceutical Industries Ltd (TEVA)

Ken Griffin is a man known to be raring to take a risk when it …

Read more

From Wall Street to the Great Wall: Marshall Wace Pours Millions Into Momo Inc (ADR) (MOMO) and Alibaba Group Holding Ltd (BABA)

A glimpse into Q3 plays in the Chinese tech-verse from a firm that managed to turn a profit in a post-Brexit world.

Read more

Polar’s Gavin Rochussen Bets on Payment Firms Square Inc (SQ) and PayPal Holdings Inc (PYPL)

Will investing in Square and PayPal help new CEO Rochussen turn his fund around?

Read more